Pfizer Worldwide Research, Development & Medical, Pearl River, NY.
Pfizer Worldwide Research, Development & Medical, Cambridge, MA.
Vet Pathol. 2022 Jul;59(4):516-527. doi: 10.1177/03009858221092015. Epub 2022 Apr 22.
Translational models have played an important role in the rapid development of safe and effective vaccines and therapeutic agents for the ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Animal models recapitulating the clinical and underlying pathological manifestations of COVID-19 have been vital for identification and rational design of safe and effective vaccines and therapies. This manuscript provides an overview of commonly used COVID-19 animal models and the pathologic features of SARS-CoV-2 infection in these models in relation to their clinical presentation in humans. Also discussed are considerations for selecting appropriate animal models for infectious diseases such as COVID-19, the host determinants that can influence species-specific susceptibility to SARS-CoV-2, and the pathogenesis of COVID-19. Finally, the limitations of currently available COVID-19 animal models are highlighted.
在由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起的持续的 2019 年冠状病毒病(COVID-19)大流行中,转化模型在安全有效的疫苗和治疗药物的快速开发中发挥了重要作用。能够重现 COVID-19 临床和潜在病理表现的动物模型对于安全有效的疫苗和疗法的鉴定和合理设计至关重要。本文概述了常用于 COVID-19 的动物模型,以及这些模型中 SARS-CoV-2 感染的病理特征与其在人类中的临床表现之间的关系。还讨论了选择 COVID-19 等传染病的合适动物模型的注意事项、影响 SARS-CoV-2 种特异性易感性的宿主决定因素,以及 COVID-19 的发病机制。最后,强调了目前可用的 COVID-19 动物模型的局限性。